ImmunityBio, Inc. IBRX

$IBRX who ever sell at this moment might cry on next monday. The good news would be your bad news haha

$IBRX last hour to be rich....

$IBRX could be double digits next monday if good news announce

$IBRX will close above 4

$IBRX added 1000 shares. Target double digit.

09/10/2023 08:30AM ETABVC BioPharma Receives Taiwanese Patent for Its Treatment of Major Depressive Disorder (MDD)The Company Holds a US Patent for the Same TreatmentFREMONT, CA, Oct. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, announced today that it received a Taiwanese patent, Application No. 109130285, for the use of PDC-1421, a Radix Polygala (Polygala tenuifolia Willd) extract, which is used in the Company's asset ABV-1504 for the treatment of Major Depressive Disorder (MDD). The Company was previously awarded a U.S. patent, US 11,554,154 B2, on April 25, 2023, for the same treatment."These patents grant ABVC the right to exclude others from using, offering, or selling PDC-1421, throughout the United States and Taiwan until the year of 2040," said Dr. Uttam Patil, ABVC Chief Executive Officer. "As our patent map steps into global coverage, we eagerly await the results of patent applications in the European Union, China, Japan, and more."The patent application was submitted to the Taiwan Patent and Trademark Office under the title "Polygala Extract for the Treatment of Major Depressive Disorder." The invention relates to oral administration of the formulation containing a Radix Polygala (Polygala tenuifolia Willd) extract, PDC-1421, as a capsule for treating Major Depressive Disorder. Based on current studies, administering the composition should be done over the course of at least 25 days, with the daily dose varying once, twice, or three times per day; each dose ranges between 380-760 mg of the botanical extraction.

If only PSS can read my postings he should be ashamed of his greediness

PSS is so greedy that he wants all the profits only for him. Not shared to investing public.

He knows by heart Anktiva will be approved that he converted his $200M loan into 250M shares to dilute the price

This is total manipulation by PSS and his henchmen to dilute the market in order for them to acquire the remaining 16% stocks the public is holding

This is a game of patience. For those who have shallow pocket will quit